Table 3

Hemoglobin, hematocrit and arterial blood gases

Baseline
 HD
 H60
 S60




PEG-albumin
 HES
 PEG-albumin
 HES
 PEG-albumin
 HES
Hematocrit (%)
 46.4 ± 1.4
 26.4 ± 0.9*b
 31.6 ± 1.1*
 18.2 ± 0.4*†
 -
 18.1 ± 0.5*†
 -
PaO2 (mmHg)
 58.9 ± 8.7
 59.5 ± 11.3b
 69.6 ± 7.0
 100.0 ± 12.8*†
 -
 121.0 ± 14.3*†‡
 -
PaCO2 (mmHg)
 59.1 ± 10.1
 59.7 ± 5.0
 51.1 ± 5.3
 45.3 ± 12.9
 -
 36.1 ± 8.1*†
 -
pH arterial
 7.388 ± 0.030
 7.387 ± 0.036
 7.349 ± 0.025
 7.251 ± 0.076*†
 -
 7.109 ± 0.047*†‡
 -
BE (mmol/l)
 5.5 ± 1.9
 5.3 ± 2.3
 1.8 ± 1.8*
 -8.2 ± 2.8*†
 -
 -18.0 ± 4.7*†
 -

Shown are changes in hemoglobin, hematocrit and arterial blood gases between the two study groups at different time points. Within the same treatment group: *versus baseline; †versus HD; ‡versus H60. Among treatments: PEG-albumin versus bHES. BE, base excess; HD, hemodilution; H60, end of the hemorrhage period; HES, hydroxyethyl starch; PaO2, arterial oxygen tension; PaCO2, arterial carbon dioxide tension; PEG-albumin, polyethylene glycol-conjugated human serum albumin; S60, end of the experiment.

Martini et al. Critical Care 2008 12:R54   doi:10.1186/cc6874